Clinical Trial Update: Open-label Investigation of the Safety and Effectiveness of DIABECELL® in Patients With Type 1 Diabetes Mellitus [Phase 1, Phase 2]

View source ↗

Summary

Open-label Phase 1/2 trial evaluating safety and effectiveness of DIABECELL in patients with Type 1 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• DIABECELL

Snippet

Sponsor: Diatranz Otsuka Limited | Conditions: Type 1 Diabetes | Phase 1, Phase 2 | Status: COMPLETED